Digital Treatment for Dizziness

[INQ. NO. 2511E08] NeuroEars is a venture company established in 2021 that is developing digital treatments for dizziness.
To this end, NeuroEars is developing medical software (SaMD) that measures dizziness based on virtual reality, a diagnostic module that analyzes dizziness based on artifi cial intelligence — and vestibular rehabilitation content that treats dizziness, based on virtual reality and artifi cial intelligence.
NeuroEars has released medical software that measures dizziness after receiving Class-2 medical device approval from the Ministry of Food and Drug Safety, and is expecting that its vestibular rehabilitation content will be released this year.

Dizziness measurement medical software
NeuroEars-Anna, dizziness measurement software, is medical software that measures dizziness based on a virtual reality device (HMD). NeuroEars-Anna allows you to perform all 18 dizziness tests without any additional hardware.
NeuroEars-Anna provides the same VOR test function as the existing nystagmometer, and also provides oculomotor tests and SVV/SVH test functions using virtual reality.Additionally, because it is virtual reality-based software, there are no space limitations, and the optimal system can always be provided to users through remote maintenance.

NeuroEars-Anna is virtual reality-based medical software that has obtained Class-2 medical device approval from the Ministry of Food and Drug Safety. It is the first in Korea to be recognized by the Health Insurance Review and Assessment Service for insurance premiums. NeuroEars-Anna is currently in use at over 70 medical institutions.
NeuroEars is expanding its market by offering its product at a significantly lower price compared to competing products that offer similar functions.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods